NCT06344052 2024-09-20To Assess the Safety and Efficacy of SP-002 with Vismodegib for the Treatment of Locally Advanced Basal Cell CarcinomaStamford Pharmaceuticals, Inc.Phase 2 Recruiting80 enrolled